$GTCH With a touch of a finger, beams of light measure the

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
130
$GTCH With a touch of a finger, beams of light measure the amount of oxygen in your blood by analyzing the color and movement of blood cells. Dark red blood cells indicate a lack of oxygen, while bright red blood cells indicate higher oxygen level. For example, if 96% of the blood cells are bright red, while 4% are dark red, then the Sp02 (Oxygen) level would be 96%. When a finger is placed on the qTerm device, a light source emits intense light. A light detector detects the light that passed through the finger, measuring how much was absorbed. A computer program performs an accurate calculation to produce numerical results. One of the main advantages of pulse and oxygen oximetry is the fact that it is a painless and noninvasive method. Oxygen saturation is an important measure to indicate proper functionality of our lungs. As we breath, our lungs pass oxygen into tiny blood vessels called capillaries. The capillaries transport oxygen-rich blood to our organs. The heart pumps the blood through arteries to the rest of the body to maintain constant supply of oxygen. In case of improper lung functionality, blood oxygen saturation declines, potentially putting our organs in danger. A pulse/oxygen oximeter can quickly detect a drop in oxygen saturation and alert for medical intervention.

https://www.marketwatch.com/press-release/gbt...ws_seemore
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Rollins' Current Market Position and Outlook

Updated Category News Views 226

Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...

Continue Reading
Silver One Reports Major Mineral Resource Estimate for Candelaria

Updated Category News Views 199

Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....

Continue Reading
Investors Alert: Zynex (ZYXI) Faces Serious Legal Scrutiny

Updated Category News Views 197

Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...

Continue Reading
Understanding Rentokil Initial's Stock Valuation Insights

Updated Category News Views 100

Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...

Continue Reading
Innovative Insights on Efzofitimod from aTyr Pharma's Recent Conference

Updated Category News Views 177

aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...

Continue Reading